Cysteinyl Leukotriene Levels in Esophageal Mucosal Biopsies of Children with Eosinophilic Inflammation: Are They All the Same?
dc.contributor.author | Gupta, Sandeep K. | en_US |
dc.contributor.author | Peters-Golden, Marc L. | en_US |
dc.contributor.author | Fitzgerald, Joseph F. | en_US |
dc.contributor.author | Croffie, Joseph M. | en_US |
dc.contributor.author | Pfefferkorn, Marian D. | en_US |
dc.contributor.author | Molleston, Jean P. | en_US |
dc.contributor.author | Corkins, Mark R. | en_US |
dc.contributor.author | Lim, Joel R. | en_US |
dc.date.accessioned | 2010-06-01T22:30:46Z | |
dc.date.available | 2010-06-01T22:30:46Z | |
dc.date.issued | 2006-05 | en_US |
dc.identifier.citation | Gupta, Sandeep K.; Peters-Golden, Marc; Fitzgerald, Joseph F.; Croffie, Joseph M.; Pfefferkorn, Marian D.; Molleston, Jean P.; Corkins, Mark R.; Lim, Joel R. (2006). "Cysteinyl Leukotriene Levels in Esophageal Mucosal Biopsies of Children with Eosinophilic Inflammation: Are They All the Same?." The American Journal of Gastroenterology 101(5): 1125-1128. <http://hdl.handle.net/2027.42/75498> | en_US |
dc.identifier.issn | 0002-9270 | en_US |
dc.identifier.issn | 1572-0241 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75498 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16573772&dopt=citation | en_US |
dc.format.extent | 178602 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | 2006 by Am. Coll. of Gastroenterology | en_US |
dc.title | Cysteinyl Leukotriene Levels in Esophageal Mucosal Biopsies of Children with Eosinophilic Inflammation: Are They All the Same? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Division of Pediatric Gastroenterology, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana | en_US |
dc.identifier.pmid | 16573772 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75498/1/j.1572-0241.2006.00557.x.pdf | |
dc.identifier.doi | 10.1111/j.1572-0241.2006.00557.x | en_US |
dc.identifier.source | The American Journal of Gastroenterology | en_US |
dc.identifier.citedreference | Levine MS, Saul SH. Idiopathic eosinophilic esophagitis: How common is it? Radiology 1993; 186: 631 – 2. | en_US |
dc.identifier.citedreference | Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503 – 12. | en_US |
dc.identifier.citedreference | Straumann A, Spichtin HP, Grize L, et al. Natural history of primary eosinophilic esophagitis: A follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003; 125: 1660 – 9. | en_US |
dc.identifier.citedreference | Steiner SJ, Gupta SK, Croffie JM, et al. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24-hour pH monitoring. Am J Gastroenterol 2004; 99: 801 – 5. | en_US |
dc.identifier.citedreference | Gupta SK, Fitzgerald JF, Chong SK, et al. Vertical lines in distal esophageal mucosa (VLEM): A true endoscopic manifestation of esophagitis in children? Gastrointest Endosc 1997; 45: 485 – 9. | en_US |
dc.identifier.citedreference | Lim JR, Gupta SK, Fitzgerald JF, et al. White specks in esophageal mucosa (WSEM): An endoscopic manifestation of non-reflux eosinophilic esophagitis (EE) in children. Gastrointest Endosc 2004; 59: 835 – 8. | en_US |
dc.identifier.citedreference | Liacouras CA, Wenner WJ, Brown K, et al. Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26: 380 – 5. | en_US |
dc.identifier.citedreference | Faubion WA Jr, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27: 90 – 3. | en_US |
dc.identifier.citedreference | Gupta SK, Fitzgerald JF, Davis MM, et al. Treatment of allergic eosinophilic esophagitis (AEE) with oral prednisone (P) and swallowed fluticasone (F): A randomized, prospective study in children. Gastroenterology 2003; 124: A19. | en_US |
dc.identifier.citedreference | Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003; 98: 777 – 82. | en_US |
dc.identifier.citedreference | Whelan GJ, Blake K, Kissoon N, et al. Effect of montelukast on time-course of exhaled nitric oxide in asthma: Influence of LTC 4 synthase A −444 C polymorphism. Pediatr Pulmonol 2003; 36: 413 – 20. | en_US |
dc.identifier.citedreference | Bisgaard H. Leukotriene modifiers in pediatric asthma management. Pediatrics 2001; 107: 381 – 90. | en_US |
dc.identifier.citedreference | Sing JT Jr, Jones BA. Leukotriene receptor antagonist as a new mode of therapy for eosinophilic gastroenteritis. Am J Gastroenterol 2001; 96: S245. | en_US |
dc.identifier.citedreference | Vanderhoof JA, Young RJ, Hanner TL, et al. Montelukast: Use in pediatric patients with eosinophilic gastrointestinal disease. J Pediatr Gastroenterol Nutr 2003; 36: 293 – 4. | en_US |
dc.identifier.citedreference | Attwood SEA, Lewis CJ, Bronder CS, et al. Eosinophilic oesophagitis: A novel treatment using montelukast. Gut 2003; 52: 181 – 5. | en_US |
dc.identifier.citedreference | Wilborn J, Crofford LJ, Burdick MD, et al. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995; 95: 1861 – 8. | en_US |
dc.identifier.citedreference | Salvi SS, Krishna MT, Sampson AP, et al. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001; 119: 1533 – 46. | en_US |
dc.identifier.citedreference | Schwartz DA, Pardi DS, Murray JA. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci 2001; 46: 1787 – 90. | en_US |
dc.identifier.citedreference | Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: A randomised double-blind placebo-controlled trial. Lancet 2001; 357: 2007 – 11. | en_US |
dc.identifier.citedreference | Smith LJ. Newer asthma therapies. Ann Intern Med 1999; 130: 531 – 2. | en_US |
dc.identifier.citedreference | Friesen CA, Kearns GL, Andre L, et al. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004; 38: 343 – 51. | en_US |
dc.identifier.citedreference | Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann Intern Med 1999; 130: 487 – 95. | en_US |
dc.identifier.citedreference | Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann Allergy Asthma Immunol 2003; 90: 23 – 7. | en_US |
dc.identifier.citedreference | Gupta SK, Fitzgerald JF, Chong SKF, et al. Long term outcome of vertical lines in the (distal) esophageal mucosa (VLEM) and eosinophilic esophagitis: A prospective study. Gastrointest Endosc 1996; 43: 327. | en_US |
dc.identifier.citedreference | Wilborn J, Bailie M, Coffey M, et al. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1996; 97: 1827 – 36. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.